Market Place
Sourcing Support
Biotricity Boosts Q3 2026 Revenue And EBITDA Expansion
11 Feb 2026 //
GLOBENEWSWIRE
Biotricity Announces Fiscal 2026 Q3 Growth on Feb. 11, 2024
05 Feb 2026 //
GLOBENEWSWIRE
Biotricity Boosts Profitability Path In Q2 2026 With Margins
14 Nov 2025 //
GLOBENEWSWIRE
Biotricity To Host Q2 2026 Financial Results Call On November
07 Nov 2025 //
GLOBENEWSWIRE
Biotricity Starts Fiscal 2026 with Strong Q1 Results, Revenue
14 Aug 2025 //
GLOBENEWSWIRE
Biotricity`s Q1 2026 Financial Results & Update Call on Aug 14
12 Aug 2025 //
GLOBENEWSWIRE
Biotricity Achieves Strong Fiscal 2025 Results with Revenue
17 Jul 2025 //
GLOBENEWSWIRE
Biotricity`s Fiscal 2025 Q4 Results & Business Update on July 18
15 Jul 2025 //
GLOBENEWSWIRE
Biotricity Named Fastest-Growing Company by Financial Times
08 Apr 2025 //
GLOBENEWSWIRE
Biotricity Strengthens IP With 14 New Patents
12 Mar 2025 //
GLOBENEWSWIRE
Biotricity Posts Record Margins, Revenue, Cashflow With 21.7% Growth
20 Feb 2025 //
GLOBENEWSWIRE
Biotricity Hits Cashflow Breakeven With 11% Revenue Increase
17 Feb 2025 //
GLOBENEWSWIRE
Biotricity Achieves Sales Growth, Margins in Q2 FY 2025
15 Nov 2024 //
GLOBENEWSWIRE
Biotricity to Host Q2 FY 2025 Results & Business Update
13 Nov 2024 //
GLOBENEWSWIRE
Biotricity Provides Updates Guidance For Earlier Profitability
03 Oct 2024 //
ACCESSWIRE
Biotricity Reports Improved Margins In First Quarter Fiscal Year 2025
21 Aug 2024 //
ACCESSWIRE
Biotricity Announces Accelerated Path to EBITDA Positive
11 Jul 2024 //
ACCESSWIRE
Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening
28 Jun 2024 //
ACCESSWIRE
Biotricity Reports for Fiscal Year 2024, Accelerating the Company Profit
27 Jun 2024 //
ACCESSWIRE
Biotricity To Host Q4 & FY 2024 Financial Results Call On June 27
26 Jun 2024 //
ACCESSWIRE
Biotricity Guides To Meet Revenue, Beat Loss/Margin Targets
06 Jun 2024 //
ACCESSWIRE
Biotricity: Preferred Holders Convert Almost All Preferred A To Common
04 Jun 2024 //
ACCESSWIRE
Biotricity Cardiac Home Screening Service Targets 1B Heart Market
30 May 2024 //
ACCESSWIRE
Biotricity Expands To Pulmonary, Neurology Via Home Diagnostic Tie-Ups
30 Apr 2024 //
ACCESSWIRE
Biotricity`s Path To Breakeven Accelerated By Biotres Pro Demand
26 Apr 2024 //
ACCESSWIRE
Biotricity Launches Major Cardiac Monitoring Hospital Pilot
18 Apr 2024 //
ACCESSWIRE
Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network
16 Apr 2024 //
ACCESSWIRE
Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients
02 Apr 2024 //
ACCESSWIRE
Biotricity Partners with Third Major Group Organization
28 Mar 2024 //
ACCESSWIRE
Biotricity Partners with a Second Top Group Purchasing Organization
05 Mar 2024 //
ACCESSWIRE
Biotricity Receives Health Canada Clearance for Biotres
29 Feb 2024 //
ACCESSWIRE
Biotricity Strengthens its Foundation for Growth
21 Feb 2024 //
ACCESSWIRE
Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results
19 Feb 2024 //
ACCESSWIRE
Biotricity to Announce Operational Efficiency for Q3 of Fiscal Year 2024
14 Feb 2024 //
ACCESSWIRE
Biotricity Delivers Record Margins and Sales Growth for Q2 of Fiscal Year 2024
14 Nov 2023 //
ACCESSWIRE
Biotricity to Host Second Quarter Fiscal Year 2024 Financial Results
10 Nov 2023 //
ACCESSWIRE
Biotricity Releases Another Groundbreaking Product: Biotres Pro
31 Oct 2023 //
ACCESSWIRE
Biotricity Announces Patient Filing for Cutting-Edge Biotres Device
03 Oct 2023 //
ACCESSWIRE
Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024
15 Aug 2023 //
ACCESSWIRE
Biotricity to Host First Quarter Fiscal Year 2024 Financial Results
14 Aug 2023 //
ACCESSWIRE
Biotricity Shows Strength in its Fundamentals on its Path to Profitability
11 Aug 2023 //
ACCESSWIRE
Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
26 Jul 2023 //
ACCESSWIRE
Biotricity Regains Nasdaq Listing Compliance
21 Jul 2023 //
ACCESSWIRE
Biotricity Reports Strong Start to Fiscal Year 2024
06 Jul 2023 //
ACCESSWIRE
Biotricity to Host Fiscal Year 2023 Financial Results Call on June 30th
26 Jun 2023 //
ACCESSWIRE
Biotricity CEO Speaks to the Future of AI and its Contributions to Healthcare
23 May 2023 //
ACCESSWIRE
Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth
16 May 2023 //
ACCESSWIRE
Biotricity Reaches $12M Revenue Run Rate in March with Promising Future Growth
19 Apr 2023 //
ACCESSWIRE
Leading Medical Biometric Firm Biotricity Releases First Corporate Impact Report
11 Apr 2023 //
ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2023 Third Quarter
14 Feb 2023 //
ACCESSWIRE
Biotricity To Host Fiscal 2023 Q3 Financial Results Call on February 14th
09 Feb 2023 //
ACCESSWIRE
Biotricity Selected to Present Work on AI Stroke Prediction in CKD Patients
03 Feb 2023 //
ACCESSWIRE
Biotricity Signs Agreement With 5 Distributor for Cardiac Monitoring Solutions
26 Jan 2023 //
ACCESSWIRE
Biotricity to Participate in the Healthcare IT Conference Presented by Maxim
23 Jan 2023 //
ACCESSWIRE
Biotricity Files FDA 510(k) for Form Factor of Biotres Cardiac Monitoring Device
12 Dec 2022 //
ACCESSWIRE
Biotricity Surpasses $10 Million in Annual Revenue Run Rate
21 Nov 2022 //
ACCESSWIRE
Biotricity Signs Agreement to Expand Access for its Cardiac Monitoring Solutions
16 Nov 2022 //
ACCESSWIRE
Biotricity Launches Cardiac Disease Management Solution Following 2 Pilots
26 Oct 2022 //
ACCESSWIRE
Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion Evolution
13 Oct 2022 //
ACCESSWIRE
